Name: ankylosing spondylitis and klebsiella (en Inglés)
Price: 348830.00 CLP
Availability: InStock
Author: Ebringer, Alan
ISBN: 9781447142997

portada ankylosing spondylitis and klebsiella (en Inglés)

Formato

Libro Físico

Autor

Alan Ebringer

Editorial

Springer

Año

2012

Idioma

Inglés

N° páginas

256

Encuadernación

Tapa Dura

Dimensiones

24.0 x 15.8 x 2.0 cm

Peso

0.66 kg.

ISBN

1447142993

ISBN13

9781447142997

Categorías

Reumatología

ankylosing spondylitis and klebsiella (en Inglés)

Alan Ebringer (Autor) · Springer · Tapa Dura

Libro Nuevo

$ 348.830

$ 484.480

Ahorras: $ 135.650

28% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 03 de Mayo y el Martes 14 de Mayo.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "ankylosing spondylitis and klebsiella (en Inglés)"

Ankylosing spondylitis and Klebsiella is a comprehensive and informative text on the cause of Ankylosing spondylitis. Ankylosing spondylitis (AS) is a condition which affects 20 million people worldwide and is likely caused or initiated by a bowel infection from Klebsiella bacteria. When a patient is infected by Klebsiella bacteria, his or her immune system will make antibodies against all the antigens or molecules found in the microbe. Because some of the bacterial antigens resemble self tissues, the anti-bacterial antibodies will attack not only the bacteria but also the self tissues such as the joints and the cells having the same HLA molecules, which is how the disease AS starts. This is the concept of molecular similarity or "molecular mimicry" which previously has been found to work in two other autoimmune diseases; rheumatic fever and rheumatoid arthritis. The first paper on this subject was published in 1976 and since then over 100 papers on rheumatological topics have been published, from Prof Ebringer's group, at the Division of Life Sciences, King's College in London, UK. The relevant information from these papers is extracted and presented in this book format making it accessible to health professionals, research institutions, pharmaceutical companies and universities and the general public.